{"id":17116,"date":"2023-06-29T00:31:00","date_gmt":"2023-06-28T16:31:00","guid":{"rendered":"https:\/\/flcube.com\/?p=17116"},"modified":"2024-12-08T00:42:58","modified_gmt":"2024-12-07T16:42:58","slug":"changchun-bcht-biotechnology-to-acquire-full-stake-in-mrna-rd-firm-transcend-biomedical","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=17116","title":{"rendered":"Changchun BCHT Biotechnology to Acquire Full Stake in mRNA R&amp;D Firm Transcend Biomedical"},"content":{"rendered":"\n<p>China-based Changchun BCHT Biotechnology Co., Ltd (<a href=\"https:\/\/www.google.com\/finance\/quote\/688276:SHA\">SHA: 688276<\/a>) has announced its intention to invest in and gradually acquire a 100% stake in its compatriot firm, Transcend Biomedical (Suzhou) Co., Ltd. The investment will be made in installments, with the first phase amounting to RMB 150 million (USD 20.7 million). This strategic move is aimed at establishing BCHT as a key player in the mRNA research and development (R&amp;D) space.<\/p>\n\n\n\n<p><strong>Investment in mRNA Technology and Licensing Deal<\/strong><br>Transcend Biomedical, valued at RMB 701.1 million (USD 97 million) in terms of net assets as of March 31, 2023, has already made significant strides in the mRNA sector. In May 2021, the company struck a non-exclusive licensing deal with Acuitas, securing rights to the latter\u2019s lipid nanoparticle (LNP) delivery technology to support the development of its mRNA vaccines. This technology is crucial for the efficient delivery of mRNA vaccines and has positioned Transcend as a competitive player in the mRNA therapeutics market.<\/p>\n\n\n\n<p><strong>BCHT&#8217;s Expansion into mRNA R&amp;D<\/strong><br>The acquisition of Transcend Biomedical aligns with BCHT&#8217;s ambition to expand its presence in the mRNA R&amp;D space. By acquiring a 100% stake in Transcend, BCHT will gain access to cutting-edge mRNA technology and expertise, enhancing its capabilities in developing innovative mRNA-based therapies and vaccines.<a href=\"https:\/\/flcube.com\">-Fineline Info &amp; Tech<\/a><\/p>\n\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>China-based Changchun BCHT Biotechnology Co., Ltd (SHA: 688276) has announced its intention to invest in&#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":false,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10],"tags":[1843,63,1844,2647],"class_list":["post-17116","post","type-post","status-publish","format-standard","hentry","category-company","category-deals","tag-bcht-biotechnology","tag-mrna","tag-sha-688276","tag-transcend-biomedical"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Changchun BCHT Biotechnology to Acquire Full Stake in mRNA R&amp;D Firm Transcend Biomedical - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"China-based Changchun BCHT Biotechnology Co., Ltd (SHA: 688276) has announced its intention to invest in and gradually acquire a 100% stake in its compatriot firm, Transcend Biomedical (Suzhou) Co., Ltd. The investment will be made in installments, with the first phase amounting to RMB 150 million (USD 20.7 million). This strategic move is aimed at establishing BCHT as a key player in the mRNA research and development (R&amp;D) space.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=17116\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Changchun BCHT Biotechnology to Acquire Full Stake in mRNA R&amp;D Firm Transcend Biomedical\" \/>\n<meta property=\"og:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=17116\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2023-06-28T16:31:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-12-07T16:42:58+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1894\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=17116#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=17116\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Changchun BCHT Biotechnology to Acquire Full Stake in mRNA R&amp;D Firm Transcend Biomedical\",\"datePublished\":\"2023-06-28T16:31:00+00:00\",\"dateModified\":\"2024-12-07T16:42:58+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=17116\"},\"wordCount\":227,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"keywords\":[\"BCHT Biotechnology\",\"mRNA\",\"SHA: 688276\",\"Transcend Biomedical\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=17116#respond\"]}],\"copyrightYear\":\"2023\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=17116\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=17116\",\"name\":\"Changchun BCHT Biotechnology to Acquire Full Stake in mRNA R&amp;D Firm Transcend Biomedical - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"datePublished\":\"2023-06-28T16:31:00+00:00\",\"dateModified\":\"2024-12-07T16:42:58+00:00\",\"description\":\"China-based Changchun BCHT Biotechnology Co., Ltd (SHA: 688276) has announced its intention to invest in and gradually acquire a 100% stake in its compatriot firm, Transcend Biomedical (Suzhou) Co., Ltd. The investment will be made in installments, with the first phase amounting to RMB 150 million (USD 20.7 million). This strategic move is aimed at establishing BCHT as a key player in the mRNA research and development (R&D) space.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=17116#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=17116\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=17116#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Changchun BCHT Biotechnology to Acquire Full Stake in mRNA R&amp;D Firm Transcend Biomedical\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Changchun BCHT Biotechnology to Acquire Full Stake in mRNA R&amp;D Firm Transcend Biomedical - Insight, China&#039;s Pharmaceutical Industry","description":"China-based Changchun BCHT Biotechnology Co., Ltd (SHA: 688276) has announced its intention to invest in and gradually acquire a 100% stake in its compatriot firm, Transcend Biomedical (Suzhou) Co., Ltd. The investment will be made in installments, with the first phase amounting to RMB 150 million (USD 20.7 million). This strategic move is aimed at establishing BCHT as a key player in the mRNA research and development (R&D) space.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=17116","og_locale":"en_US","og_type":"article","og_title":"Changchun BCHT Biotechnology to Acquire Full Stake in mRNA R&amp;D Firm Transcend Biomedical","og_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","og_url":"https:\/\/flcube.com\/?p=17116","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2023-06-28T16:31:00+00:00","article_modified_time":"2024-12-07T16:42:58+00:00","og_image":[{"width":2560,"height":1894,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","type":"image\/jpeg"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=17116#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=17116"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Changchun BCHT Biotechnology to Acquire Full Stake in mRNA R&amp;D Firm Transcend Biomedical","datePublished":"2023-06-28T16:31:00+00:00","dateModified":"2024-12-07T16:42:58+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=17116"},"wordCount":227,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"keywords":["BCHT Biotechnology","mRNA","SHA: 688276","Transcend Biomedical"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=17116#respond"]}],"copyrightYear":"2023","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=17116","url":"https:\/\/flcube.com\/?p=17116","name":"Changchun BCHT Biotechnology to Acquire Full Stake in mRNA R&amp;D Firm Transcend Biomedical - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"datePublished":"2023-06-28T16:31:00+00:00","dateModified":"2024-12-07T16:42:58+00:00","description":"China-based Changchun BCHT Biotechnology Co., Ltd (SHA: 688276) has announced its intention to invest in and gradually acquire a 100% stake in its compatriot firm, Transcend Biomedical (Suzhou) Co., Ltd. The investment will be made in installments, with the first phase amounting to RMB 150 million (USD 20.7 million). This strategic move is aimed at establishing BCHT as a key player in the mRNA research and development (R&D) space.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=17116#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=17116"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=17116#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Changchun BCHT Biotechnology to Acquire Full Stake in mRNA R&amp;D Firm Transcend Biomedical"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/17116","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=17116"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/17116\/revisions"}],"predecessor-version":[{"id":17118,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/17116\/revisions\/17118"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=17116"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=17116"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=17116"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}